Neratinib Maleate is used as an adjuvant therapy in people with early stage breast cancer in which HER2 is overexpressed, after the person receives treatment with trastuzumab. It is a tyrosine kinase inhibitor anticancer drug. Reference standards of Neratinib Maleate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Neratinib Maleate - API Standards [catalogue_number] => PA 14 75000 [category_ids] => ,79,80,71,81,78,70,82, [chemical_name] => [weight] => 673.11 [form] => C34H33ClN6O7 [cas] => 915942-22-2 [pslug] => 915942-22-2-neratinib-maleate-api-pa1475000 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 14 75000
CAS :
Molecular Formula : C34H33ClN6O7
Molecular Weight : 673.11
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
